Correlation Between China Development and Easywell Biomedicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Development and Easywell Biomedicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Development and Easywell Biomedicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Development Financial and Easywell Biomedicals, you can compare the effects of market volatilities on China Development and Easywell Biomedicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Development with a short position of Easywell Biomedicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Development and Easywell Biomedicals.

Diversification Opportunities for China Development and Easywell Biomedicals

-0.79
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between China and Easywell is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding China Development Financial and Easywell Biomedicals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Easywell Biomedicals and China Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Development Financial are associated (or correlated) with Easywell Biomedicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Easywell Biomedicals has no effect on the direction of China Development i.e., China Development and Easywell Biomedicals go up and down completely randomly.

Pair Corralation between China Development and Easywell Biomedicals

Assuming the 90 days trading horizon China Development Financial is expected to generate 0.25 times more return on investment than Easywell Biomedicals. However, China Development Financial is 4.07 times less risky than Easywell Biomedicals. It trades about 0.18 of its potential returns per unit of risk. Easywell Biomedicals is currently generating about -0.36 per unit of risk. If you would invest  1,585  in China Development Financial on September 13, 2024 and sell it today you would earn a total of  215.00  from holding China Development Financial or generate 13.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

China Development Financial  vs.  Easywell Biomedicals

 Performance 
       Timeline  
China Development 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in China Development Financial are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, China Development showed solid returns over the last few months and may actually be approaching a breakup point.
Easywell Biomedicals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Easywell Biomedicals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

China Development and Easywell Biomedicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Development and Easywell Biomedicals

The main advantage of trading using opposite China Development and Easywell Biomedicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Development position performs unexpectedly, Easywell Biomedicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Easywell Biomedicals will offset losses from the drop in Easywell Biomedicals' long position.
The idea behind China Development Financial and Easywell Biomedicals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories